← Back to Search

Botanical Preparation

Myalgesin for Osteoarthritis

Phase 3
Waitlist Available
Led By Stuart I Erner, MD
Research Sponsored by ProThera, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 days
Awards & highlights

Study Summary

Myalgesin is a botanical preparation consisting of celery seed extract,extract of dried Boswellia serrata, and dried extract of Phellodendron bark. Component of these extracts have been shown to exert anti-inflammatory effects and to inhibit cyclooxygenase and 5-lipooxygenase. The study is based on the hypothesis that oral administrration of this botanical will support joint function in people with osteoarthritis of the knee and improve symptoms and mobility as measured by the Western Ontario and McMaster Universities (WOMAC) Osteoarthritis Index.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 90 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Western Ontario and McMaster Universities (WOMAC) Osteoarthritis Index
Secondary outcome measures
Lesquesne Algofunctional Index

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: MyalgesinExperimental Treatment1 Intervention
Subjects receive Myalgesin twice daily
Group II: AcetaminophenActive Control1 Intervention
Subjects receive acetaminophen 1000 mg three times a day

Find a Location

Who is running the clinical trial?

ProThera, Inc.Lead Sponsor
Stuart I Erner, MDPrincipal InvestigatorPrivate Practice

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
New York
How old are they?
65+
What site did they apply to?
Stuart I. Erner, MD
What portion of applicants met pre-screening criteria?
Met criteria
~6 spots leftby Apr 2025